Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1820 of 5804
-
Chemo-Free stem cell transplant could change thalassemia treatment
Disease control Recruiting nowYunnan is a high-incidence area of Eastern Mediterranean (thalassemia) in China, and the treatment cost of thalassemia patients is high, hematopoietic stem cell transplantation (HSCT) is the only means to cure thalassemia, but there are problems in donor screening and the risk of…
Phase: NA • Sponsor: Hu Peng • Aim: Disease control
Last updated Jun 26, 2026 13:17 UTC
-
New MRI-Guided radiation aims to hit tumors harder, spare healthy tissue
Disease control Recruiting nowTo determine if the investigators are able to deliver highly focused, intense radiation to tumours in the abdominal region or chest cavity whilst limiting the dose to surrounding organs using a high field strength MR-Linac.
Sponsor: The Christie NHS Foundation Trust • Aim: Disease control
Last updated Jun 26, 2026 13:29 UTC
-
New shield could make heart procedures safer for medical teams
Disease control Recruiting nowDoctors and nurses who perform heart procedures using X-ray guidance are exposed to radiation, which can be harmful over time. This exposure increases the risk of certain health problems, including cancers, eye damage (cataracts), and DNA damage. Although protective lead clothing…
Phase: NA • Sponsor: Liverpool Heart and Chest Hospital NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New kidney stone surgery could be just as effective, less invasive
Disease control CompletedThis study, known as the FLAME Trial (Flexible ureteroscopy for Lower pole stones And Mini-pErcutaneous nephrolithotomy), is an international, multicenter, randomized, non-inferiority trial. It aims to compare the effectiveness and safety of flexible ureteroscopy using a flexible…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New cancer drug SHR-7782 enters human testing
Disease control Recruiting nowThe main objective of this study is to evaluate the effectiveness and safety of SHR-7782 for participants with advanced malignant cancer.
Phase: PHASE1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Which method best catches hospital errors? study puts four to the test
Knowledge-focused OngoingThe goal of this observational study is to learn about the incidence and characteristics of adverse events (AEs) among hospitalized patients in China and to compare 4 commonly used methods for detecting these events. The main questions it aims to answer are: How common are AEs a…
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
New robot could transform hysterectomy surgery
Disease control OngoingThe purpose of this research is to evaluate the safety and performance of the investigational Medtronic Hugo™ Robotic Assisted Surgery (RAS) system when used during hysterectomy procedures, including patients being treated for cancer.
Phase: NA • Sponsor: Medtronic - MITG • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Bladder emptying test may spare pregnant women invasive needles
Diagnosis OngoingTemplate-Based Brief Summary (Sağlık Profesyonelleri İçin) Study Title: The Negative Predictive Value of First-Trimester Fetal Bladder "Rapid Emptying" (≤40 minutes and post-void ≤2 mm) for Major Chromosomal Aneuploidies: A Prospective Diagnostic Accuracy Study. Purpose: To e…
Sponsor: Haseki Training and Research Hospital • Aim: Diagnosis
Last updated Jun 26, 2026 16:29 UTC
-
Math model aims to perfect thyroid drug doses for kids
Disease control Recruiting nowThe aim of this multicentric, randomised, two-arms and single-blinded clinical trial is to prospectively evaluate OptiThyDose for Congenital hypothyroidism (CH) and Graves' disease (GD).
Phase: NA • Sponsor: University Children's Hospital Basel • Aim: Disease control
Last updated Jun 26, 2026 12:48 UTC
-
Proton beam therapy offers new hope for breast cancer recurrence without mastectomy
Disease control Recruiting nowBreast cancer is the most common malignancy in women. Breast-conserving surgery (BCS) with adjuvant whole-breast irradiation (WBI) is currently the standard of care in the oncological treatment of primary breast cancer and offers an equivalent alternative to mastectomy. The prima…
Phase: NA • Sponsor: University Hospital Heidelberg • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
AI could revolutionize cancer diagnosis with new pathology model
Knowledge-focused Recruiting nowHistopathology remains the gold standard for disease diagnosis, yet faces challenges including pathologist shortages and diagnostic model limitations. This underscores the critical need to develop deep learning-based pathology foundation models integrating prospective imaging and…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Which catheter is best for stroke clot removal? new trial aims to find out
Knowledge-focused Recruiting nowThe purpose of this clinical trial is to study the two main types of approaches used in stroke thrombectomy and to investigate if one approach is more effective than the other, as this is currently not known. This study will be conducted in adults who have been diagnosed with an …
Phase: NA • Sponsor: University of South Florida • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
New radioactive drug aims to shrink hard-to-treat prostate cancer
Disease control Recruiting nowThis open-label clinical study investigates 3D1015 Injection (Lu 177-PSMA-3D1015) in adult males with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC). Participants will receive intravenous infusions of 3D1015, with treatm…
Phase: PHASE1 • Sponsor: Chunjing Yu • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New pill targets Hard-to-Treat cancers in early human trial
Disease control Recruiting nowThis is a first-in-human clinical study of PEP08, a novel cancer therapy being evaluated both as monotherapy and in combination with other treatments in patients with advanced or metastatic solid tumors harboring MTAP deletion. The study will be conducted in three parts, with Pa…
Phase: PHASE1 • Sponsor: PharmaEngine • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Smart oxygen monitoring could help preterm babies breathe easier
Disease control Recruiting nowThe project is a national, prospective, multicenter, interventional pilot project focused on controlled remote monitoring and optimization of oxygen therapy for premature infants in the Czech Republic. The primary aim of the project is to prepare, test, and develop a proposal for…
Phase: NA • Sponsor: Institute of Health Information and Statistics of the Czech Republic • Aim: Disease control
Last updated Jun 26, 2026 14:44 UTC
-
Cancer-Killing virus trial launches for patients out of options
Disease control Recruiting nowThis is a Phase I clinical trial evaluating an investigational treatment called IDOV-Immune, a type of oncolytic virus therapy, for adults with advanced solid tumors that have not responded to standard treatments. Oncolytic viruses are designed to infect and destroy cancer cells …
Phase: PHASE1 • Sponsor: ViroMissile, Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New program helps families act while waiting for autism diagnosis
Knowledge-focused Recruiting nowA growing body of literature documents the benefits of parent-mediated interventions for autism starting early in life . However, the median age of diagnosis in the US continues to be 49 months. Even following formal diagnosis, services often do not begin for another 9 months on …
Phase: NA • Sponsor: Drexel University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New combo aims to keep advanced lung cancer in check
Disease control Recruiting nowThis prospective clinical study aims to evaluate and observe the efficacy and safety of adebrelimab combined with etoposide capsules in maintenance therapy for extensive-stage small cell lung cancer using a single-arm trial design. The study is planned to be conducted in Shaanxi…
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New Alzheimer's drug targets brain receptors to boost memory
Symptom relief Recruiting nowThe purpose of this study is to evaluate the safety and tolerability of NSC001 on in patients with mild to moderate Alzheimer's disease and to evaluate the influence of the compound on cognitive function.
Phase: PHASE1, PHASE2 • Sponsor: NSC-Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
E-cigarettes offered to cancer patients who refuse to quit smoking
Disease control ENROLLING_BY_INVITATIONFor patients in cancer care, quitting smoking is critical, but a significant portion of patients in cancer care refuse all components of tobacco treatment, even when offered free of charge. The proposed clinical trial will assess one harm reduction intervention, switching complet…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC